Who has invested in OSE Immunotherapeutics?

No investors are named on the public record for OSE Immunotherapeutics yet.

OSE Immunotherapeutics Funding: $21M Raised, IPO

OSE Immunotherapeutics funding overview

OSE Immunotherapeutics is based in Nantes, France. OSE Immunotherapeutics has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is an IPO.

OSE Immunotherapeutics at a glance

Total raised: $21M
Latest round: IPO
Headquarters: Nantes, France

Frequently asked about OSE Immunotherapeutics funding

How much has OSE Immunotherapeutics raised?: OSE Immunotherapeutics has raised $21M in total disclosed funding across the rounds on record.
Who has invested in OSE Immunotherapeutics?: No investors are named on the public record for OSE Immunotherapeutics yet.
What was the latest OSE Immunotherapeutics funding round?: The most recent disclosed round is an IPO.
Where is OSE Immunotherapeutics based?: OSE Immunotherapeutics is based in Nantes, France.

OSE Immunotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Nantes below to benchmark round size and investor mix.

OSE Immunotherapeutics Funding: $21M Raised, IPO

OSE Immunotherapeutics funding overview

OSE Immunotherapeutics at a glance

Frequently asked about OSE Immunotherapeutics funding

Companies related to OSE Immunotherapeutics (31)

Browse related funding lists (2)